OIG cautions against diagnosis coding fueled by chart reviews, HRAs
The manipulation of chart reviews and the vendor-led increase of in-home health risk assessments (HRA) may be inflating diagnosis coding levels, and be warned: The OIG and other federal groups are closely monitoring the activity.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.